Singapore's GIC invests in German pharma company Cheplapharm

Sovereign wealth fund and Atlantic Park investing nearly $550m

20221026 Cheplapharm

Cheplapharm says it will use its latest funding to fuel growth. © AP

MARS W. MOSQUEDA JR., DealStreetAsia

CEBU, Philippines -- German pharmaceutical Cheplapharm says it has raised 550 million euros ($547 million) in structured investment from Singapore sovereign wealth fund GIC and Atlantic Park.

Atlantic Park is a joint venture between global growth equity company General Atlantic and credit-focused asset manager Iron Park Capital Partners.

Sponsored Content

About Sponsored ContentThis content was commissioned by Nikkei's Global Business Bureau.